|1.||Mukainaka, Teruo: 1 article (03/2002)|
|2.||Kasahara, Yoshimasa: 1 article (03/2002)|
|3.||Akihisa, Toshihiro: 1 article (03/2002)|
|4.||Tokuda, Harukuni: 1 article (03/2002)|
|5.||Ichiishi, Eiichiro: 1 article (03/2002)|
|6.||Suzuki, Hiroyuki: 1 article (03/2002)|
|7.||Yasukawa, Ken: 1 article (03/2002)|
|8.||Ukiya, Motohiko: 1 article (03/2002)|
|9.||Nishino, Hoyoku: 1 article (03/2002)|
07/01/1996 - "Two taraxastane-type hydroxy triterpenes, taraxasterol and faradiol, isolated from the flowers of Compositae plants Cynara scolymus (artichoke) and Chrysanthemum morifilolium (chrysanthemum), respectively, showed strong inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice. "
10/01/1996 - "Ten dihydroxy- and trihydroxy triterpenes, viz., four taraxastanes: faradiol, heliantriol B0, heliantriol C and arnidiol; two lupanes: calenduladiol and heliantriol B2; two oleananes: maniladiol and longispinogenin; and two ursanes: brein and uvaol, isolated from the nonsaponifiable lipids of the flower extracts of Compositae plants were evaluated with respect to their anti-inflammatory activity against 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice. "
03/08/2002 - "Fifteen pentacyclic triterpene diols and triols, consisting of: six taraxastanes, faradiol (1), heliantriol B0 (2), heliantriol C (3), 22alpha-methoxyfaradiol (4), arnidiol (5), and faradiol alpha-epoxide (6); five oleananes, maniladiol (7), erythrodiol (8), longispinogenin (9), coflodiol (10), and heliantriol A(1) (11); two ursanes, brein (12) and uvaol (13); and two lupanes, calenduladiol (14) and heliantriol B2 (15), isolated from the non-saponifiable lipid fraction of the edible flower extract of chrysanthemum (Chrysanthemum morifolium) were evaluated for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate, in Raji cells as a primary screening test for anti-tumor-promoters. "
|8.||Epstein-Barr virus early antigen